...
首页> 外文期刊>Cardiology research and practice >Clinical Phenotypes and Age-Related Differences in Presentation, Treatment, and Outcome of Heart Failure with Preserved Ejection Fraction: A Vietnamese Multicenter Research
【24h】

Clinical Phenotypes and Age-Related Differences in Presentation, Treatment, and Outcome of Heart Failure with Preserved Ejection Fraction: A Vietnamese Multicenter Research

机译:临床表型和年龄相关的介绍,治疗和结果与保存的射血分数的介绍,治疗和结果:越南多中心研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background . Heart failure with preserved ejection fraction (HFpEF) is a rising health problem with heterogeneous presentation and no evidence-based treatment. While Southeast Asia reported the highest mortality and morbidity among Asian population, little is known about the Vietnamese population, including patient characteristics, prescribing pattern and mortality rate. Methods . We conducted an observational study on 477 patients diagnosed with HFpEF from seven hospitals in Southern Vietnam from January 2019 to December 2019. Results . Mean age was 67.6 (40.9%??65 years). 62.3% were female. 82.4% were diagnosed within 5 years. Dyspnea, congestion, and hypoperfusion on admission were noted in 63.9%, 48.8%, and 4.6% of the patients, respectively. Median ejection fraction was 63%. Valvular heart disease (VHD) was the leading cause of heart failure (35.9%). 78.6% had at least two comorbidities, mostly hypertension (68.6%). 30.6% of the patients were hospitalized, with a median stay of 7.0 (4.0–10.0) days and inhospital mortality of 4.8%. Older patients (≥65 years) were more likely to be females (OR?=?1.52); had multimorbid conditions (OR?=?3.14), including hypertension (OR?=?4.28), diabetes (OR?=?1.73), coronary artery disease (CAD) (OR?=?2.50), dyslipidemia (OR?=?1.94), and chronic kidney disease (OR?=?2.44); and were more frequently prescribed statin (OR?=?3.15). Younger individuals (65 years) were associated with higher mineralocorticoid antagonist uptake (OR?=?0.52) and VHD (OR?=?0,40). Prescription rate for renin-angiotensin-aldosterone system inhibitor, beta blocker, mineralocorticoid antagonist, and loop diuretic was 72.5%, 59.1%, 43.0%, and 60.6%, respectively. Four phenotypes were identified, including the lean/elderly/multimorbid; congestive/metabolic; CAD-induced; and younger/atrial fibrillation (AF)/VHD. The novel phenotype “younger/AF/VHD” exhibited high symptom burden and poor functional capacity despite being the youngest and least multimorbid. The “lean/elderly/multimorbid” phenotype demonstrated the highest symptom severity and inhospital mortality. Conclusions . Our research highlights a younger, predominantly female population with high disease burden. The four novelly identified phenotypes provide contemporary and pragmatic insights into a phenotype-guided approach, exclusively targeting the Vietnamese population.
机译:背景 。与射血分数(HFPEF)心脏衰竭是一种新兴的健康问题与异构演示和没有证据为基础的治疗。虽然东南亚报亚裔人口中最高的死亡率和发病率,鲜为人知的是,越南的人口,包括病人的特点,规定的图案和死亡率。方法 。我们进行了477例患者的观察研究,从七家医院在越南南部诊断为HFPEF从2019一月到十二月2019年的结果。平均年龄为67.6(40.9%LT;?65岁)。 62.3%为女性。 82.4%被诊断5年之内。呼吸困难,充血,血流灌注不足入院的63.9%,48.8%,和病人的4.6%分别被注意到。平均射血分数为63%。心脏瓣膜病(VHD)是心脏衰竭(35.9%)的主要原因。 78.6%的人至少有两个合并症,主要是高血压(68.6%)。患者30.6%的住院治疗,用的7.0(4.0-10.0)天的中位数住宿和4.8%,住院死亡率。老年患者(≥65岁)更可能是女性(OR = 1.52?);有multimorbid条件(OR = 3.14),包括高血压(OR = 4.28),糖尿病(OR = 1.73),冠状动脉疾病(CAD)(OR = 2.50),血脂异常(OR =? 1.94),和慢性肾脏疾病(OR = 2.44)?;并且更常见的处方他汀类药物(OR = 3.15)。年轻的个体(小于65岁)与较高的盐皮质激素拮抗剂摄取(?OR = 0.52)和VHD(?OR = 0.40)相关联。用于肾素 - 血管紧张素 - 醛固酮系统抑制剂,β阻断剂,盐皮质激素拮抗剂,和袢利尿剂处方率为72.5%,59.1%,43.0%,和60.6%之间。四和表型鉴定,包括精益/老人/ multimorbid;充血性/代谢; CAD诱导;和年轻/房颤(AF)/ VHD。尽管是最年轻的和至少multimorbid新颖表型“年轻/ AF / VHD”显示出高的症状负荷和功能性的能力较差。 “精益/老人/ multimorbid”表型表现出最高的症状严重程度和住院期间的死亡率。结论。我们的研究强调了年轻化,以女性为主的人群具有较高的疾病负担。四个新奇标识的表型提供现代,务实的洞察表型制导方式,仅定位于越南的人口。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号